CD8A and neoplasm: Due to complete tumor remission in the CT26 model, no samples from the combination group could be analyzed; however, the anti-PD-1 monotherapy caused significantly increased intratumoral CD3 and CD8 levels, and the copanlisib group showed the same trend.